Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - 21 CFR Part 14
          - [Docket No. FDA-2023-N-3497]

# AGENCY:

Food and Drug Administration, Department of Health and Human Services (HHS).

# ACTION:

Final rule.

# SUMMARY:

The Food and Drug Administration (FDA or the Agency) is announcing the termination of the Board of Tea Experts by the Federal Tea Tasters Repeal Act of 1996. This document removes the Board of Tea Experts from the Agency's list of standing advisory committees. FDA is also updating the statutory citation to the Federal Advisory Committee Act to reflect recodification. This technical change aligns with the desire of Congress to incorporate various provisions that were enacted separately over a period of years; reorganize them; conforming style and terminology; modernizing obsolete language; and correcting drafting errors to remove ambiguities, contradictions, and other imperfections without changing the meaning of or effect of existing law.

# DATES:

This rule is effective September 19, 2023.

# FOR FURTHER INFORMATION CONTACT:

                        Michael Ortwerth, Advisory Committee Oversight and Management Staff, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5103, Silver Spring, MD 20993-0002, 301-796-8220; or                         *ACOMSSubmissions@fda.hhs.gov.*

# SUPPLEMENTARY INFORMATION:

The Board of Tea Experts was established on March 2, 1897, by the Tea Importation Act of 1897 (Pub. L. 54-358, section 2, March 2, 1897, 29 Stat. 604). The Board was responsible for making recommendations to the Secretary of the Treasury to fix and establish uniform standards of purity, quality, and fitness for consumption of all kinds of teas imported into the United States. The Board was terminated by the Federal Tea Tasters Repeal Act of 1996 (Pub. L. 104-128, section 3, April 9, 1996, 110 Stat. 1198). This document aligns FDA's list of standing advisory committees with existing law by removing the Board of Tea Experts.

                    Additionally, with the passage of the Act of December 27, 2022 (Pub. L. 117-286, 136 Stat. 4196), Congress made revisions in title 5 of the U.S. Code, as necessary to keep the title current and to make technical amendments to improve the U.S. Code. In doing so, it recodified the Federal Advisory Committee Act to chapter 10 of the U.S. Code. Thus, the appropriate regulatory citation to the Federal Advisory Committee Act is now 5 U.S.C. 1001*et seq.*                     With this final rule, the new citation is updated in the authority citation of part 14 (21 CFR part 14).                

                    Under 5 U.S.C. 553(b)(4)(B) and (d)(3) and 21 CFR 10.40(d) and (e), the Agency finds good cause to dispense with notice and public comment procedures and to proceed to an immediate effective date on this rule. Notice and public comment and a delayed effective date are unnecessary and not in the public interest as the Board was terminated by statute in 1996, and this final rule merely removes the name of the Board of Tea Experts from the list of standing advisory committees in § 14.100 (21 CFR 14.100) and updates the authority citation of 21 CFR part 14 to appropriately cite the Federal Advisory Committee Act (5 U.S.C. 1001*et seq.*). This is a technical amendment to conform the citation to the recodification enacted on December 27, 2022, and does not substantively alter the legal authority underlying part 14.                

Therefore, the Agency is amending the authority citation of part 14 and § 14.100(a) as set forth in the regulatory text of this document.

# List of Subjects in 21 CFR Part 14

      - Administrative practice and procedure
      - Advisory committees
      - Color additives
      - Drugs
      - Radiation protection

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 14 is amended as follows:

# PART 14—PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE

1. The authority citation for part 14 is revised to read as follows: 

Authority:5 U.S.C. 1001*et seq.;*15 U.S.C. 1451-1461; 21 U.S.C. 41-50, 141-149, 321-394, 467f, 679, 821, 1034; 28 U.S.C. 2112; 42 U.S.C. 201, 262, 263b, 264, 284m, 284m-1; Pub. L. 107-109, 115 Stat. 1419.                        

§ 14.100

2. Amend § 14.100 by removing paragraph (a)(1) and redesignating paragraphs (a)(2) through (5) as paragraphs (a)(1) through (4). 

Dated: September 12, 2023.

Lauren K. Roth,

Associate Commissioner for Policy.

[FR Doc. 2023-20012 Filed 9-18-23; 8:45 am]

BILLING CODE 4164-01-P